Home > News > Cell Signaling Technology and Zeptosens AG Enter Agreement
April 19th, 2004
Cell Signaling Technology and Zeptosens AG Enter Agreement
Abstract:
Cell Signaling Technology, Inc. and Zeptosens AG, announced the signing of a supply and license agreement, for the use and resale of certain CST reagents by Zeptosens in conjunction with its ZeptoMARK(TM) protein microarray platform. These reagents include phospho-specific antibodies to key signaling molecules and important therapeutic targets for pharmaceutical drug discovery such as kinases.
Source:
Businesswire
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||